AstraZeneca (NYSE: AZN) announced today that Gaithersburg, Md., will be one of three global research and development centers to improve ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE